TOP TIERMARKET NEWSWIRE
News & sentiment

FORTE BIOSCIENCES IN Equity (FBRX) — News & AI sentiment

FORTE BIOSCIENCES IN Equity (FBRX) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 56/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 56/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

FBRX news in the last 24 hours, 7 days, 30 days and 90 days

How much FBRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowFBRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days656/100FBRX headlines →
Last 90 days6562.8/100FBRX headlines →

Latest stories on FBRX

Aug 27
Forte Biosciences, Inc. (FBRX) files 8-K
SEC 8-K50 · neutralgeneral
Aug 27
Aug 27
Aug 27
Aug 27
Aug 19
Aug 14
Aug 12
Aug 11
Aug 11
Aug 8
Aug 6
Aug 5
Jul 30
Jul 29
Jul 28
Jul 28
Barclays cuts Forte Biosciences stock rating on acquisition terms
Investing.com Analyst Ratings34 · bearishanalyst
Jul 28
Jul 28
Jul 27
Jul 27
Jul 27
Jul 27
Jul 27
Jul 27
Open FBRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →